Impact of the Use of Ketamine in Laparoscopic Surgery.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03724019|
Recruitment Status : Active, not recruiting
First Posted : October 30, 2018
Last Update Posted : February 28, 2022
|Condition or disease||Intervention/treatment|
|Quality of Recovery||Drug: Ketamine|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||125 participants|
|Target Follow-Up Duration:||2 Days|
|Official Title:||Evaluation of the Impact of the Use of Ketamine in Laparoscopic Surgery, Using the Quality of Recovery 15 Questionnaire.|
|Actual Study Start Date :||October 1, 2018|
|Estimated Primary Completion Date :||October 1, 2022|
|Estimated Study Completion Date :||December 1, 2022|
20 milliliter of ketamine (0.5mg / kg ideal body weight) at induction of anesthesia.
Administration of 0.5mg / kg ideal body weight of ketamine at induction of anesthesia in laparoscopic surgery.
20 milliliter of sodium chloride at induction of anesthesia.
- Impact in QoR-15 score [ Time Frame: 6 months ]Difference (improvement or worsening) in the postoperative baseline score (preoperative) in the Portuguese version of the Quality of Recovery questionnaire 15.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03724019
|CHU São João|
|Porto, Portugal, 4200|